Abbott LaboratoriesvsInfuSystems

ABT and INFU stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$104.71

Value $182B

-2.55%
ABT's page

INFU

InfuSystems Holdings, Inc.

$14.79

Value $299M

+0.00%
INFU's page

Abbott Laboratories (ABT) has a market value of $182B and InfuSystems (INFU) $299M. Over the last year, with dividends, ABT moved -17.8% and INFU +55.5%. The P/E is 38.7 for ABT and 31.7 for INFU. Dividend yield: ABT 2.41%, INFU none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$182B

    INFU$299M

    ABT is 609 times INFU

  • Revenue, 12 months

    ABT$48.2B

    INFU$144M

    ABT is 334 times INFU

  • Net income, 12 months

    ABT$4.7B

    INFU$9.4M

    ABT is 498 times INFU

  • Operating margin

    ABT13.8%

    INFU9.8%

    4.0 points apart

  • ROIC

    ABT6.3%

    INFU12.7%

    6.4 points apart

  • P/E

    ABT38.7

    INFU31.7

    ABT is 1.2 times INFU

  • Dividend yield

    ABT2.4%

    INFU0.0%

    2.4 points apart

  • 5-year return

    ABT-11.6%

    INFU-16.8%

    5.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-11.6%

INFU-16.8%

25507510020222023202420252026
Returns by period
PeriodABTWith dividendsINFUWith dividends
1 year since November 14, 2025-17.8%Price -19.8%+55.5%Price +55.5%
3 years since November 17, 2023+12.0%+3.9% a yearPrice +5.2%+59.2%+16.8% a yearPrice +59.2%
5 years since November 16, 2021-11.6%-2.4% a yearPrice -20.0%-16.8%-3.6% a yearPrice -16.8%
10 years since November 18, 2016+217.1%+12.2% a yearPrice +162.8%+721.7%+23.4% a yearPrice +721.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesINFUInfuSystems

Valuation

ABTINFU
Valuation
Price$104.71$14.79
Market value$182B$299M
Enterprise value (EV)$209B$310M
P/E38.731.7
P/E, 5-year median33.7–
P/B3.64.7
EV/EBIT31.421.8
Free cash flow yield3.7%8.3%

Results and growth

ABTINFU
Results and growth
Revenue, 12 months$48.2B$144M
Net income, 12 months$4.7B$9.4M
Free cash flow, 12 months$6.8B$25M
Earnings per share, 12 months$2.69$0.44
Revenue growth, year on year5.7%6.4%
Revenue growth a year, past+5.1%over 5 years+8.1%over 5 years
EPS growth a year, past+8.3%over 5 years-17.3%over 5 years

Margins and returns on capital

ABTINFU
Margins and returns on capital
Gross margin56.9%57.6%
Operating margin13.8%9.8%
Net margin9.8%6.5%
ROIC6.3%12.7%
ROE9.1%16.0%

Balance sheet

ABTINFU
Balance sheet
Cash$4.3B$9.1M
Total debt$31.2B$24M
Net debt / EBITDA3.30.4
Interest cover6.7×13.8×

Dividends and buybacks

ABTINFU
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$2.52–
Dividend growth a year, past+10.4%over 5 years–
Buyback yield0.5%3.3%
Shareholder yield2.9%3.3%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or INFU

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or InfuSystems?

By market value, Abbott Laboratories ($182B) is about 608.6 times InfuSystems ($299M), at today's prices.

How did ABT and INFU stock do over the last 10 years?

Since November 18, 2016, ABT's price moved +162.8% and INFU's +721.7%. With dividends: ABT +217.1% (+12.2% a year), INFU +721.7% (+23.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or INFU?

The dividend yield at today's price is 2.41% for Abbott Laboratories and none for InfuSystems. Over the last twelve months they paid $2.52 and – per share.

What is the P/E of ABT and INFU?

At today's price, the P/E is 38.7 for ABT and 31.7 for INFU. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Abbott Laboratories or InfuSystems?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 6.5% for InfuSystems, and the operating margin 13.8% and 9.8%. Revenue was $48.2B and $144M.

Which is the better investment, Abbott Laboratories or InfuSystems?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.